V. Thon et al., ANTIGEN PRESENTATION BY COMMON VARIABLE IMMUNODEFICIENCY (CVID) B-CELLS AND MONOCYTES IS UNIMPAIRED, Clinical and experimental immunology, 108(1), 1997, pp. 1-8
CVID is a primary immunodeficiency syndrome comprising a heterogeneous
group of patients with hypogammaglobulinaemia and defective formation
of specific antibodies. Previous studies demonstrated defective T cel
l responsiveness to antigen in a major subgroup of patients. In the pr
esent study we investigated the capacity of peripheral blood monocytes
and Epstein-Barr virus (EBV)-transformed B cell lines from seven pati
ents with CVID, including two patients expressing an extended MHC hapl
otype described to be associated with CVID, to present antigen (Tet. T
ox.) to CD4(+) antigen-specific T cell lines from healthy controls. Th
e results presented show an unimpaired capacity of peripheral blood mo
nocytes to present antigen in all patients studied. In addition, the p
resent study demonstrates for the first time that CVID B cells functio
n normally as antigen-presenting cells (APC). These findings indicate
that expression of a certain MHC phenotype in CVID is not associated w
ith a defect in the presentation of recall antigen by monocytes and B
cells. Based on these studies, uptake, processing and re-expression of
recall antigen in association with MHC class II molecules on the APC
surface are functional and there is no indication far structural abnor
malities of the MHC class II molecules expressed by the patients studi
ed that could be essential for their function in antigen binding and p
resentation.